Jieyu Guo

Dr. Jieyu Guo

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2018 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
XZXinyue Zhang
Xinyue Zhang
JGJieyu Guo
Jieyu Guo
XWXiangxiang Wei
Xiangxiang Wei
CNCong Niu
Cong Niu
MJMengping Jia
Mengping Jia
DMDan Meng
Dan Meng
The transcription factor BTB and CNC homology 1 (Bach1) is widely expressed in most mammalian tissues and functions primarily as a transcriptional suppressor by heterodimerizing with small Maf proteins and binding to Maf recognition elements in the promoters of targeted genes. It has a key regulatory role in the production of reactive oxygen species, cell cycle, heme homeostasis, hematopoiesis, and immunity and has been shown to suppress ischemic angiogenesis and promote breast cancer metastasis. This review summarizes how Bach1 controls these and other cellular and physiological and pathological processes. Bach1 expression and function differ between different cell types. Thus, therapies designed to manipulate Bach1 expression will need to be tightly controlled and tailored for each specific disease state or cell type.

1 March 2019 in Science Advances
Verified
Journal Article
Open access
PDF file
XWXiangxiang Wei
Xiangxiang Wei
JGJieyu Guo
Jieyu Guo
QLQinhan Li
Qinhan Li
QJQianqian Jia
Qianqian Jia
QJQing Jing
Qing Jing
DMDan Meng
Dan Meng
Bach1 is a key determinant of pluripotency, self-renewal, and cell fate determination in human embryonic stem cells.

8 June 2020 in Journal of Cellular Physiology
Verified
Journal Article
Open access
PDF file
JGJieyu Guo
Jieyu Guo
XWXiangxiang Wei
Xiangxiang Wei
QLQinhan Li
Qinhan Li
LLLiliang Li
Liliang Li
ZYZhaohua Yang
Zhaohua Yang
DMDan Meng
Dan Meng
Coronavirus disease‐2019 (COVID‐19) is a global pandemic with high infectivity and pathogenicity, accounting for tens of thousands of deaths worldwide. Recent studies have found that the pathogen of COVID‐19, severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), shares the same cell receptor angiotensin converting enzyme II (ACE2) as SARS‐CoV. The pathological investigation of COVID‐19 deaths showed that the lungs had characteristics of pulmonary fibrosis. However, how SARS‐CoV‐2 spreads from the lungs to other organs has not yet been determined. Here, we performed an unbiased evaluation of cell‐type‐specific expression of ACE2 in healthy and fibrotic lungs, as well as in normal and failed adult human hearts, using published single‐cell RNA‐seq data. We found that ACE2 expression in fibrotic lungs mainly locates in arterial vascular cells, which might provide a route for bloodstream spreading of SARS‐CoV‐2. Failed human hearts have a higher percentage of ACE2‐expressing cardiomyocytes, and SARS‐CoV‐2 might attack cardiomyocytes through the bloodstream in patients with heart failure. Moreover, ACE2 was highly expressed in cells infected by respiratory syncytial virus or Middle East respiratory syndrome coronavirus and in mice treated by lipopolysaccharide. Our findings indicate that patients with pulmonary fibrosis, heart failure, and virus infection have a higher risk and are more susceptible to SARS‐CoV‐2 infection. The SARS‐CoV‐2 might attack other organs by getting into the bloodstream. This study provides new insights into SARS‐CoV‐2 blood entry and heart injury and might propose a therapeutic strategy to prevent patients from developing severe complications.

21 December 2023 in Nature Communications
Verified
Journal Article
Open access
PDF file
JJJiayu Jin
Jiayu Jin
YHYunquan He
Yunquan He
JGJieyu Guo
Jieyu Guo
QPQi Pan
Qi Pan
XWXiangxiang Wei
Xiangxiang Wei
DMDan Meng
Dan Meng
Hepatic insulin resistance is central to the metabolic syndrome. Here we investigate the role of BTB and CNC homology 1 (BACH1) in hepatic insulin signaling. BACH1 is elevated in the hepatocytes of individuals with obesity and patients with non-alcoholic fatty liver disease (NAFLD). Hepatocyte-specific Bach1 deletion in male mice on a high-fat diet (HFD) ameliorates hyperglycemia and insulin resistance, improves glucose homeostasis, and protects against steatosis, whereas hepatic overexpression of Bach1 in male mice leads to the opposite phenotype. BACH1 directly interacts with the protein-tyrosine phosphatase 1B (PTP1B) and the insulin receptor β (IR-β), and loss of BACH1 reduces the interaction between PTP1B and IR-β upon insulin stimulation and enhances insulin signaling in hepatocytes. Inhibition of PTP1B significantly attenuates BACH1-mediated suppression of insulin signaling in HFD-fed male mice. Hepatic BACH1 knockdown ameliorates hyperglycemia and improves insulin sensitivity in diabetic male mice. These results demonstrate a critical function for hepatic BACH1 in the regulation of insulin signaling and glucose homeostasis.

2 September 2025 in Stem Cell Research & Therapy
Verified
Journal Article
Open access
PDF file
JMJinghua Ma
Jinghua Ma
SMSiyu Ma
Siyu Ma
CNCong Niu
Cong Niu
SWSiqing Wang
Siqing Wang
XWXiangxiang Wei
Xiangxiang Wei
JGJieyu Guo
Jieyu Guo
Genomic studies have linked single nucleotide variants in the enhancer region of the leukemia inhibitory factor receptor (Lifr) gene to chromatin accessibility and the regulation of self-renewal in mouse embryonic stem cells (mESCs). However, the underlying mechanisms remain unclear. This study investigates the role of the transcription factor BTB and CNC homology 1 (BACH1) in regulating the Lifr enhancer and its impact on mESC pluripotency. We performed RNA-sequencing (RNA-seq) to assess the impact of Bach1 knockout on gene expression in mESCs. Additionally, chromatin immunoprecipitation (ChIP), co-immunoprecipitation (co-IP), and luciferase reporter gene analysis were employed to investigate the mechanism by which BACH1 regulates Lifr expression. Genomic analyses identified BACH1 binding at the Lifr enhancer proximal to rs50454566 in mESCs. Integrated single-cell RNA sequencing (scRNA-seq) data revealed co-upregulation of Bach1 and Lifr in inner cell mass (ICM) cells. RNA-seq analyses demonstrated that Bach1 depletion attenuated Lifr expression and impeded LIFR-signal transducer and activator of transcription 3 (STAT3) signaling. Mechanistically, BACH1 recruited STAT3 to the Lifr enhancer, driving Lifr transcription and facilitating the LIFR-STAT3 signaling pathway, thereby enhancing mESC self-renewal. Our findings demonstrate that BACH1 enhances Lifr enhancer activity by recruiting STAT3 and activates the LIFR-STAT3 signaling pathway by promoting the LIFR expression, thereby maintaining mESC self-renewal. Our results complement a novel insight into the regulatory role of BACH1 in maintaining the self-renewal capacity of mESCs.

15 May 2026 in Nature Communications
Verified
Journal Article
Open access
PDF file
SMSiyu Ma
Siyu Ma
NJNan Jiang
Nan Jiang
ZZZheng Zuo
Zheng Zuo
ZLZhipeng Lian
Zhipeng Lian
JWJian Wu
Jian Wu
DMDan Meng
Dan Meng
Latent transforming growth factor β-binding protein 4 (LTBP4) has been reported to be associated with heart failure (HF), but its role in HF remains unclear. We observe increased LTBP4 expression in plasma and cardiomyocytes of HF patients, and in a male mouse HF model induced by transverse aortic constriction (TAC). Cardiomyocyte-specific Ltbp4 deficiency attenuates NLRP3 inflammasome activation, cardiac dysfunction, and fibrosis post-TAC. Mechanistically, pressure overload upregulates LTBP4 partially via the transcription factor SP1. Angiotensin II promotes the recruitment of intracellular LTBP4 to the microtubule-organizing center (MTOC) via dynein. Subsequently, LTBP4 facilitates the dynein-mediated NLRP3 translocation to the MTOC and promotes NLRP3-NEK7 interaction, thereby driving NLRP3 inflammasome activation. Additionally, LTBP4 upregulates NLRP3 transcription and correlates positively with NLRP3 and interleukin-1β in HF patients. Here we show that LTBP4 is an important regulator of the NLRP3-NEK7 interaction and NLRP3 inflammasome activation in cardiomyocytes, highlighting its potential as a therapeutic target for HF.